These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11030484)

  • 1. A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome.
    Hickie IB; Wilson AJ; Wright JM; Bennett BK; Wakefield D; Lloyd AR
    J Clin Psychiatry; 2000 Sep; 61(9):643-8. PubMed ID: 11030484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome.
    White PD; Cleary KJ
    Int Clin Psychopharmacol; 1997 Jan; 12(1):47-52. PubMed ID: 9179634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
    Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
    Radat F; Berlin I; Spreux-Varoquaux O; Elatki S; Ferreri M; Puech AJ
    Psychopharmacology (Berl); 1996 Oct; 127(4):370-6. PubMed ID: 8923574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome.
    Tort S; Urrútia G; Nishishinya MB; Walitt B
    Cochrane Database Syst Rev; 2012 Apr; (4):CD009807. PubMed ID: 22513976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A catecholamine model of fatigue.
    Hickie I; Wilson A
    Br J Psychiatry; 1994 Aug; 165(2):275-6. PubMed ID: 7953052
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
    Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients.
    Monti JM
    Br J Psychiatry Suppl; 1989 Oct; (6):61-5. PubMed ID: 2619974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moclobemide in the treatment of hot flashes in postmenopausal women.
    Tarim E; Bagis T; Kilicdag E; Erkanli S; Aslan E; Kuscu E
    Adv Ther; 2002; 19(6):258-65. PubMed ID: 12665046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of moclobemide on sexual performance and nocturnal erections in psychogenic erectile dysfunction.
    Mann K; Pankok J; Leissner J; Benkert O
    Psychopharmacology (Berl); 2001 Jun; 156(1):86-91. PubMed ID: 11465638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo-controlled trial of moclobemide in social phobia.
    Schneier FR; Goetz D; Campeas R; Fallon B; Marshall R; Liebowitz MR
    Br J Psychiatry; 1998 Jan; 172():70-7. PubMed ID: 9534836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
    Baldwin DS; Green M; Montgomery SA
    Int Clin Psychopharmacol; 2014 Nov; 29(6):339-43. PubMed ID: 24859491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter.
    Müller DJ; Schulze TG; Macciardi F; Ohlraun S; Gross MM; Scherk H; Neidt H; Syagailo YV; Grässle M; Nöthen MM; Maier W; Lesch KP; Rietschel M
    Pharmacopsychiatry; 2002 Jul; 35(4):157-8. PubMed ID: 12163988
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome.
    Natelson BH; Cheu J; Pareja J; Ellis SP; Policastro T; Findley TW
    Psychopharmacology (Berl); 1996 Apr; 124(3):226-30. PubMed ID: 8740043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
    Bech P; Stage KB; Larsen JK; Vestergaard P; Gram LF;
    J Affect Disord; 2012 Nov; 140(3):253-9. PubMed ID: 22381949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
    Jouvent R; Le Houezec J; Payan C; Mikkelsen H; Fermanian J; Millet V; Dufour H
    Psychiatry Res; 1998 Jul; 79(3):267-75. PubMed ID: 9704873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid functioning during treatment for depression.
    Kusalic M; Engelsmann F; Bradwejn J
    J Psychiatry Neurosci; 1993 Nov; 18(5):260-3. PubMed ID: 8297924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary open-label study of moclobemide treatment of pain disorder.
    Pirildar S; Sezgin U; Elbi H; Uyar M; Zileli B
    Psychopharmacol Bull; 2003; 37(3):127-34. PubMed ID: 14608245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression.
    Tanghe A; Geerts S; Van Dorpe J; Brichard B; Bruhwyler J; Géczy J
    Acta Psychiatr Scand; 1997 Aug; 96(2):134-41. PubMed ID: 9272198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.